BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
Ding
Tina
T
Rheumatology Department, Royal Derby Hospital, Derby, UK. tina.ding@doctors.net.uk
Ledingham
Jo
J
Luqmani
Raashid
R
Westlake
Sarah
S
Hyrich
Kimme
K
Lunt
Mark
M
Kiely
Patrick
P
Bukhari
Marwan
M
Abernethy
Rikki
R
Bosworth
Ailsa
A
Ostor
Andrew
A
Gadsby
Kate
K
McKenna
Frank
F
Finney
Diana
D
Dixey
Josh
J
Deighton
Chris
C
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D006113:United Kingdom
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha